Pages that link to "Item:Q4785356"

The following pages link to Bayesian Approaches to Randomized Trials (Q4785356):

Displaying 50 items.

• Bayesian models and methods in public policy and government settings (Q449814) (← links)
• Implementing Bayesian predictive procedures: the \(K\)-prime and \(K\)-square distributions (Q962308) (← links)
• Simulation-based sequential Bayesian design (Q997303) (← links)
• A Bayesian approach to Weibull survival models -- application to a cancer clinical trial (Q1125992) (← links)
• Two useful distributions for Bayesian predicitve procedures under normal models (Q1298931) (← links)
• Clinician preferences and the estimation of causal treatment differences. (With comments) (Q1400099) (← links)
• Applying non-parametric robust Bayesian analysis to non-opinionated judicial neutrality (Q1598706) (← links)
• Incorporating Bayesian ideas into health-care evaluation (Q1766322) (← links)
• Bayesian statistics and the efficiency and ethics of clinical trials (Q1766323) (← links)
• Rejoinder: Approximate models and robust decisions (Q1790364) (← links)
• Incorporating external information in analyses of clinical trials with binary outcomes (Q1951537) (← links)
• Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design (Q2000854) (← links)
• Interpreting \(p\)-values and confidence intervals using well-calibrated null preference priors (Q2092891) (← links)
• Randomized phase III oncology trials: a survey and empirical Bayes inference (Q2321782) (← links)
• Prediction markets, Bayesian priors, and clinical trials (Q2382894) (← links)
• Optimal healthcare decisions: comparing medical treatments on a cost-effectiveness basis (Q2654333) (← links)
• Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests (Q3078699) (← links)
• Case-Control Analysis with Partial Knowledge of Exposure Misclassification Probabilities (Q3078786) (← links)
• Conservative prior distributions for variance parameters in hierarchical models (Q3417680) (← links)
• Bayesian approach to determine the number of subsequent users of a new treatment (Q3435346) (← links)
• The Performance of Random Coefficient Regression in Accounting for Residual Confounding (Q3436521) (← links)
• Determining the Effective Sample Size of a Parametric Prior (Q3506509) (← links)
• Hierarchical Proportional Hazards Regression Models for Highly Stratified Data (Q4668326) (← links)
• Approximate Bayesian Evaluation of Multiple Treatment Effects (Q4668402) (← links)
• A Bayesian Group Sequential Approach for Multiple Endpoints (Q4678861) (← links)
• Bayesian Evidence Accumulation in Experimental Mathematics: A Case Study of Four Irrational Numbers (Q4689856) (← links)
• Optimal sampling for repeated binary measurements (Q4818488) (← links)
• Bayesian techniques for sample size determination in clinical trials: a short review (Q4828283) (← links)
• Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable? (Q4832007) (← links)
• Reflections on Fourteen Cryptic Issues Concerning the Nature of Statistical Inference* (Q4832053) (← links)
• Bayesian index to compare assumed survival functions of two hazards following exponential distributions (Q4966778) (← links)
• (Q5101754) (← links)
• Bayesian and likelihood inference for cure rates based on defective inverse Gaussian regression models (Q5124740) (← links)
• A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials (Q5197969) (← links)
• Biostatistics in the new millennium: a consulting statistician's perspective (Q5423992) (← links)
• Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go? (Q5424155) (← links)
• Ethical considerations concerning treatment allocation in drug development trials (Q5424156) (← links)
• Bayesian analysis of multicentre trial outcomes (Q5424954) (← links)
• Why There's No Cause to Randomize (Q5426529) (← links)
• Bayesian analysis of multicentre trial outcomes (Q5442640) (← links)
• Treatment Choice With Trial Data: Statistical Decision Theory Should Supplant Hypothesis Testing (Q5868267) (← links)
• Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II (Q5868268) (← links)
• Why should clinicians care about Bayesian methods? (With discussions and response) (Q5932166) (← links)
• Statistical methods in experimentation recommendation models for discovering gene regulation pathways (Q6562688) (← links)
• Reflections on the concept of optimality of single decision point treatment regimes (Q6595094) (← links)
• Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes (Q6617468) (← links)
• Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs (Q6618333) (← links)
• Frequentist operating characteristics of Bayesian optimal designs via simulation (Q6625198) (← links)
• Decoupling power and type I error rate considerations when incorporating historical control data using a test-then-pool approach (Q6625391) (← links)
• Bayesian borrowing for basket trials with longitudinal outcomes (Q6625821) (← links)